Back to Search

KEVIN CHOW, MD

MD

Surgery Physician

NPI: 1023402096IndividualAccepts Medicare

Specialties, Licenses & Credentials

Surgery PhysicianPrimary

Surgery

Code: 208600000X

88719(GA)325709(NY)

CMS Specialties

PrimaryGENERAL SURGERY

Education

ST. LOUIS COLLEGE OF PHYSICIANS AND SURGEONS

Class of 2015

Research & Publications (20)

The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines.
PMID 17613767·Leuk Lymphoma·2007
8-other
In vivo drug-response in patients with leukemic non-Hodgkin's lymphomas is associated with in vitro chemosensitivity and gene expression profiling.
PMID 16213748·Pharmacol Res·2006
4-observational
Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.
PMID 12948851·Biochem Pharmacol·2003
8-other
In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential.
PMID 12691159·Leuk Lymphoma·2003
8-other
Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells.
PMID 11999573·Leuk Lymphoma·2002
8-other
Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
PMID 11801463·Haematologica·2002
7-preclinical
Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
PMID 11342362·Leuk Lymphoma·2001
8-other
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
PMID 11410411·Haematologica·2001
8-other
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone.
PMID 10784401·Leuk Lymphoma·2000
8-other
Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells.
PMID 11043419·Ann Hematol·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
707 E MAIN ST
MIDDLETOWN, NY 10940

Locations (2)

Practice Location

707 E MAIN ST, MIDDLETOWN, NY
(845) 333-7575

Practice Location

161 FORT WASHINGTON AVE FL 8, NEW YORK, NY
(212) 342-1734

Quick Facts

NPI
1023402096
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
11
Publications
20

Are you this provider?

Claim Your Profile